Cargando…
Melissa officinalis Protects against Doxorubicin-Induced Cardiotoxicity in Rats and Potentiates Its Anticancer Activity on MCF-7 Cells
Cardiotoxicity is a limiting factor of doxorubicin (DOX)-based anticancer therapy. Due to its beneficial effects, we investigated whether standardized extract of Melissa officinalis (MO) can attenuate doxorubicin-induced cardiotoxicity and can potentiate the efficacy of DOX against human breast canc...
Autores principales: | Hamza, Alaaeldin Ahmed, Ahmed, Mahguob Mohamed, Elwey, Hanan Mohamed, Amin, Amr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120835/ https://www.ncbi.nlm.nih.gov/pubmed/27880817 http://dx.doi.org/10.1371/journal.pone.0167049 |
Ejemplares similares
-
Green synthesis of silver nanoparticles, graphene, and silver-graphene nanocomposite using Melissa officinalis ethanolic extract: Anticancer effect on MCF-7 cell line
por: Motafeghi, Farzaneh, et al.
Publicado: (2023) -
Minerals, Essential Oils, and Biological Properties of Melissa officinalis L.
por: Abdellatif, Fahima, et al.
Publicado: (2021) -
Protective effect of nebivolol on doxorubicin-induced cardiotoxicity in rats
por: Mohamed, Enas Ahmed, et al.
Publicado: (2018) -
Does Melissa Officinalis Cause Withdrawal or Dependence?
por: Demirci, Kadir, et al.
Publicado: (2015) -
Modulation of chicken gut contractility by Melissa officinalis—ex vivo study
por: Posłuszny, Martyna A., et al.
Publicado: (2023)